Roger P-M Et Al. J Antimicrob Chemother 2024 Dec 19. Demonstrated tecovirimat efficacy against the outbreak strain. Van den berg s ja conclusions:


Roger P-M Et Al. J Antimicrob Chemother 2024 Dec 19

Van den berg s ja conclusions: Results from a phase 2 trial.

Also Annually Issue With Same Title.

Philip a, oueslati s, villa f, pannetier c, et al development of an ultrafast pcr to.

Van Den Berg S Ja Conclusions:

Mishra a, behura a, kumar a, ghosh a, naik l, mawatwal s, mohanty ss, mishra a, saha s,.

2022 Update Of The Recommendations Of The Infectious.

Images References :

Gur Z, Buhbut O, Fagan X, Tsaban G, Levy J.

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia:

Results From A Phase 2 Trial.

Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies:

European Guidelines For Primary Antifungal Prophylaxis In Adult Haematology Patients: